Brooklyn, United States
HistoWiz, founded in 2012 and headquartered in the United States, is dedicated to accelerating pathology-based research. The company provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. Their web-based platform aims to accelerate information exchange among medical scientists and research pathologists, ultimately fighting cancer cooperatively by connecting scientists and pathologists for online collaboration.
HistoWiz aims to minimize the cost of research and maximize research productivity by providing efficient services for scientists to analyze experimental pathology specimens. The company accepts formalin-fixed specimens by mail for tissue processing services. To expedite delivery of results and facilitate global collaboration, HistoWiz offers whole-slide imaging and pathology services, allowing researchers to remotely and instantly view high-magnification images of their specimens via a secure, cloud-based “virtual microscope” on any computer or mobile device without downloading any software or large files.
As of now, there is no publicly available information about HistoWiz's last investment or its investors.
The company's innovative approach to accelerating pathology-based research and its focus on collaboration and cost-effective solutions make it an interesting potential investment opportunity in the life sciences and healthcare technology sector for venture capitalists.
